Argentine researchers are participating in a clinical study that seeks to develop a trivalent vaccine that attacks the coronavirus, influenza and bronchitis.
In dialogue with Chain 3, Gonzalo Perez Marc (MN 110.813), in charge of the project, said that the investigations that took place by Covid-19 as a respiratory virus motivated the investigation of similar viruses.
/ Embedded Code Home /
Second hello of coronavirus
/ End Embed Code /
As he said, in the first instance, each one will be investigated separately and then combined. In addition, he estimated that it would be ready in “two or three years” and will be intended for the elderly.
Those who want to join as volunteers can access https://www.argvacunas.com/.
Report by Federico Albarenque.